Table S1. Genomic analysis of pre-treatment tumor in complete responder with DLBCL. Table S2. Peripheral blood cell counts of patients reported in Fig. 3 on days of peripheral blood mononuclear cell analysis with fold-change in absolute number. (DOCX 16 kb
Statistics of high-throughput sequencing and variant calling. Table S2. Somatic mutations detected b...
Table S1. Levels of peripheral blood lymphocytes of different subtypes do not differ in breast cance...
Gating strategies of monocytic MDSC and granulocytic MDSC in the peripheral blood. Gating strategies...
Figure S1. Relative percentage of FoxP3+CD4+T cells before and after treatment.. (PNG 43 kb
Toxicity. Highest grade of treatment-emergent adverse events encountered at the four different dose ...
Table S1. Patient’s characteristic of gene expression cohort. Table S2. Patient’s characteristic ex ...
Adverse events observed during immune checkpoint inhibitor therapy. (DOCX 15Â kb
Table S1. Baseline characteristics of MCL patients receiving R-CHOP like regimens and their correlat...
Table S1. Characterization of the human sample collection in the exploratory cohort. Lymphomas were ...
Table S1. Samples (n=209) sorted within tumor type by PD-L1 rank (RNA-seq). Table S2. PD-L1 (CD274) ...
This file includes: detailed information from data used, including statistical information of reads ...
Regimens of chemotherapy. Table S2. Univariate analysis of the factors affecting CR in DLBCL and BL ...
Figure S1. Flow cytometry analysis of CD45+CD33+ leukemia cells in peripheral blood of 14 and 7Â day...
Table S1. Compilation of antibodies used for Chromatin Immunoprecipitation (ChIP), Western Blot (WB)...
Supplemental digital content: 1. Genes covered in the TUM01 NGS tumor panel: list of all genes cover...
Statistics of high-throughput sequencing and variant calling. Table S2. Somatic mutations detected b...
Table S1. Levels of peripheral blood lymphocytes of different subtypes do not differ in breast cance...
Gating strategies of monocytic MDSC and granulocytic MDSC in the peripheral blood. Gating strategies...
Figure S1. Relative percentage of FoxP3+CD4+T cells before and after treatment.. (PNG 43 kb
Toxicity. Highest grade of treatment-emergent adverse events encountered at the four different dose ...
Table S1. Patient’s characteristic of gene expression cohort. Table S2. Patient’s characteristic ex ...
Adverse events observed during immune checkpoint inhibitor therapy. (DOCX 15Â kb
Table S1. Baseline characteristics of MCL patients receiving R-CHOP like regimens and their correlat...
Table S1. Characterization of the human sample collection in the exploratory cohort. Lymphomas were ...
Table S1. Samples (n=209) sorted within tumor type by PD-L1 rank (RNA-seq). Table S2. PD-L1 (CD274) ...
This file includes: detailed information from data used, including statistical information of reads ...
Regimens of chemotherapy. Table S2. Univariate analysis of the factors affecting CR in DLBCL and BL ...
Figure S1. Flow cytometry analysis of CD45+CD33+ leukemia cells in peripheral blood of 14 and 7Â day...
Table S1. Compilation of antibodies used for Chromatin Immunoprecipitation (ChIP), Western Blot (WB)...
Supplemental digital content: 1. Genes covered in the TUM01 NGS tumor panel: list of all genes cover...
Statistics of high-throughput sequencing and variant calling. Table S2. Somatic mutations detected b...
Table S1. Levels of peripheral blood lymphocytes of different subtypes do not differ in breast cance...
Gating strategies of monocytic MDSC and granulocytic MDSC in the peripheral blood. Gating strategies...